MLAB Q1 2026 Earnings Strong EPS Beat Highlights Profitability Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick CGBD Q1 2026 Earnings Slight EPS Miss as Stock Edges Lower APLS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency ASUR Q1 2026 Earnings EPS Beats Estimates by 1832 as Profitability Improves TOST Q1 2026 Earnings Profitability Surprise Drives Modest Stock Uptick VPG Q1 2026 Earnings EPS Surprises Positively Amid Quiet Revenue Report Stock Gains HBANP Q1 2026 Earnings Preferred Dividend Misses Estimates as Net Interest Margin Pressures Persist RDZN Q1 2026 Earnings Deep EPS Miss and Revenue Disclosure Gap RILYN Q1 2024 Earnings Loss Per Share of 171 Amidst Limited Financial Disclosures VUZI Q1 2026 Earnings Narrowed Loss Surprises Revenue Remains Absent